Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Oct 30, 2018 $1.61 $1.71 $1.61 $1.71 527
Oct 29, 2018 $1.82 $1.84 $1.58 $1.67 12 144
Oct 26, 2018 $1.58 $1.70 $1.54 $1.63 13 145
Oct 25, 2018 $1.62 $1.65 $1.56 $1.56 4 437
Oct 24, 2018 $1.60 $1.61 $1.60 $1.61 1 287
Oct 23, 2018 $1.59 $1.81 $1.56 $1.60 6 781
Oct 22, 2018 $1.68 $1.78 $1.65 $1.65 6 790
Oct 19, 2018 $1.70 $1.80 $1.67 $1.67 16 798
Oct 18, 2018 $1.67 $1.86 $1.67 $1.69 4 527
Oct 17, 2018 $1.85 $1.85 $1.65 $1.70 7 258
Oct 16, 2018 $1.84 $1.87 $1.77 $1.80 7 858
Oct 15, 2018 $1.90 $1.90 $1.79 $1.80 6 744
Oct 12, 2018 $1.81 $1.95 $1.77 $1.86 24 455
Oct 11, 2018 $1.87 $1.95 $1.87 $1.89 2 982
Oct 10, 2018 $2.00 $2.00 $1.80 $1.98 9 223
Oct 09, 2018 $2.00 $2.00 $1.96 $1.97 7 650
Oct 08, 2018 $1.95 $1.98 $1.95 $1.98 2 333
Oct 05, 2018 $1.98 $1.98 $1.98 $1.98 225
Oct 04, 2018 $2.04 $2.04 $1.97 $2.01 4 519
Oct 03, 2018 $2.06 $2.07 $1.97 $1.97 4 809
Oct 02, 2018 $2.03 $2.03 $2.01 $2.03 1 654
Oct 01, 2018 $2.06 $2.08 $1.99 $2.08 3 569
Sep 28, 2018 $1.99 $2.09 $1.97 $2.01 2 523
Sep 27, 2018 $2.07 $2.07 $2.02 $2.02 2 016
Sep 26, 2018 $2.00 $2.05 $1.96 $2.01 9 615
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT